Solution
SDOH-Powered Health Equity Analytics
Solution
SDOH-Powered Health Equity Analytics
Industry
Pharma & Life Sciences
Region
US
Technology
Databricks
Context
Pharma leaders face mounting challenges in addressing disparities, such as fragmented datasets and insufficient diagnosis-level granularity, especially in cancer, which in turn limit effective and timely interventions. Health equity analytics bridges this gap, delivering tumor-specific and geographically aligned insights. These scalable solutions empower commercial and marketing teams to expand brand uptake, optimize outreach, and advance equity objectives—driving both measurable market performance and improved patient outcomes.
Problem Statement
A leading global healthcare organization was facing significant limitations with their outsourced health equity analytics process. The lack of clarity on areas of underserved populace led to inconsistencies in insight quality and alignment with strategic objectives, which hindered engagement and affected outcomes, especially in tracking geographies having greatest health disparities.
Impact
- Brand Opportunity: Analysis enabled brand-specific interventions in high-disparity geographies.
- Oncology Domain Insights Expansion: Advanced analysis included health equity and SDOH insights for tumor data.
- Geography Level Expansion: Solution extended to the County-level alongside ZIP and CBSA-level data.
- Scalable Architecture: Enhanced control over business rules with scalable architecture adaptable to new tumors/ regions